Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$2.17 -3.12%
Market Cap
$60.5M
Price Target
Refer to Report
Volume
170.9K
52wk Range
$1.26 - $3
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.